Dr. Laurie Glimcher Elected to New York Blood Center Board of Trustees

Dr. Laurie H. Glimcher
Dr. Laurie H. Glimcher, the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College, was elected to the New York Blood Center Board of Trustees Thursday.
The New York Blood Center provides lifesaving blood transfusion products and medical services to metropolitan New York's 22 million residents. It also operates the National Cord Blood Program at the Howard P. Milstein National Cord Blood Center, the world's largest public cord blood bank, as well as the Lindsley F. Kimball Research Institute.
"Laurie's vast experience, energy, unique skill sets and commitment to the community will make an invaluable contribution to the Board, the entire NYBC organization and the millions of people we serve," said Howard P. Milstein, chairman of the board of the New York Blood Center.
Dr. Glimcher is a fellow of the American Academy of Arts and Sciences and a member of the National Academy of Sciences (and a member of its Institute of Medicine). She is the former president of the American Association of Immunologists. She is a member of the American Asthma Foundation, Health Care Ventures, Burroughs-Wellcome Fund and Cancer Research Institute scientific advisory boards. She serves on the Memorial Sloan Kettering Cancer Center Board of Trustees, as well as the corporate board of directors for the Bristol-Myers Squibb Pharmaceutical Corporation and the Waters Corporation.
Additional Awards and Honors
Dr. Oliver Fein, professor of clinical medicine and professor of clinical public health, received the David R. Calkins Award in Health Policy Advocacy at the Society of General Internal Medicine's 36th annual meeting April 26 in Denver, Colo. Dr. Fein was honored for his "extraordinary commitment in health policy advocacy." The society is a national medical society of 3,000 physicians who are the primary internal medicine faculty of every medical school and major teaching hospital in the United States. This award recognizes the extraordinary commitment that many members make when they choose to advocate on behalf of the society.
Dr. Madelon L. Finkel, professor of clinical public health and director of the Office of Global Health, gave an invited lecture on global health March 25 at Hacettepe University Faculty of Medicine in Ankara, Turkey. Weill Cornell and Hacettepe have signed a formal memo of understanding to focus on collaborative educational, research and clinical initiatives.
Dr. Stefano Rivella, associate professor of genetic medicine in pediatrics, has been elected director of the International BioIron Society for the 2013-2016 term. The society was founded to advance knowledge about the biological and medical roles of iron and the processes in which it participates with particular reference to those processes of medical and industrial importance.
Dr. Harel Weinstein, chairman of the Department of Physiology and Biophysics, the Maxwell M Upson Professor of Physiology and Biophysics and director of the Institute for Computational Biomedicine, was an invited member of the National Institute of Neurological Diseases and Stroke's Board of Scientific Counselors. The mission of the National Institute of Neurological Disorders and Stroke is to reduce the burden of neurological disease. The Board reviews and evaluates the institute's intramural program and the work of individual scientists in this program. Dr. Weinstein performed this work from May 12-14.